The side-effects of ciclosporine-A and tacrolimus

Clinical Nephrology

Volumn 49, Issue 6, 1998, Pages 356-363

  Mihatsch, M J ^a,f   Kyo, M ^e   Morozumi, K ^b   Yamaguchi, Y ^c   Nickeleit, V ^a   Ryffel, B ^d  

^a UNIVERSITY OF BASEL   (Switzerland)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c JIKEI UNIVERSITY HOSPITAL   (Japan)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e Hyogo Prefectural Nishinomiya Hospital   (Japan)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Ciclosporine; Nephrotoxicity; Renal transplantation; Side effects; Tacrolimus

Indexed keywords

CALCINEURIN; CYCLOSPORIN A; GLUCOSE; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ARTERIOLE; ARTERY DISEASE; ARTICLE; CHEMICAL STRUCTURE; GINGIVA HYPERPLASIA; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRICHOSIS; KIDNEY TRANSPLANTATION; NEUROTOXICITY;

CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; TACROLIMUS;

EID: 0031813980     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Alessiani M, Cillo U, Fung JJ, Irish W, Abu-Elmagd K, Jain A, Takaya S, van Thiel D, Starzl TE 1993 Adverse effects of TAC Overdosage after liver transplantation. Transplant Proc 25: 628-634
2. Binet I. Nickeleit V, Prince O, Hirsch HH, Dalquen P, Gudat F, Mihatsch MJ, Thiel G Polyoma virus infection under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss (manuscript in preparation)
3. Borel JF, Feurer C, Gubler HU, Staehelin H 1976 Biological effects of cyclosporin A: A new antilymphocytic agent. Agents Actions 6: 468-475
4. Connolly JO, Gone E, Higgins RM, O'Donnell PJ, Devlin J, Scoble JE, Williams R 1994 Renal arteriopathy associated with FK 506 therapy following liver transplantation. Nephrol Dial Transplant 9: 834-836
5. De Mottos AM, Olyaei AJ, Bennett WM 1996 Pharmacology of immunosuppressive medications used in renal diseases and transplantation. Amer J Kid Dis 28: 631-667
6. Demetris AJ, Fung JJ, Todo S, Banner B, Zerbe T, Sysyn G, Starzl TE 1990 Pathologic observations in human allograft recipients treated with TAC. Transplant Proc 22: 25-34
7. Demetris AJ, Fung JJ, Todo S, Banner B, Zerbe T, Sysyn G, Starzl TE 1990 Pathologic observations in human allograft recipients treated with TAC. Transplant Proc 22: 25-34
8. Eidelman BH, Abu-Elmagd K, Wilson J, Fung J, Alessiani M, Jain A, Takaya S, Todo SN, Tzakis A, van Thiel D, Shannon W, Starzl TE 1991 Neurologic complications of TAC. Transplant Proc 23: 3175-3178
9. Freise CE, Rowley H, Lake J, Hebert M, Ascher NL, Roberts JP 1991 Similar clinical presentation of neurotoxicity following TAC and cyclosporine in a liver transplant recipient. Transplant Proc 23: 3173-3174
10. Fries D, Rucay P, Samuel D, Hiesse C, Meduri G, Callard P, Fredj G, Bismuth H 1991 Development of renal dysfunction and renal histological lesions in two patients treated with TAC for acute rejection following liver transplantation. Transplant Proc 23: 3099-3100
11. Fruman DA, Burakoff SJ, Bierer BE 1994 Molecular actions of cyclosporin A, TAC and rapamycin. Immunosuppressive Drugs, p 15-36
12. Fung J, Abu-Elmagd K, Jain A, Cordon R, Tzakis A, Todo S, Takaya S, Alessiani M, Demetris A, Bronster O 1991 A randomized trial of primary liver transplantation under immunosuppression with TAC VS. cyclosporine. Transplant Proc 23: 2977-2983
13. Japanese TAC Study Group 1991 Japanese study of TAC on kidney transplantation: results of an early phase II study. Transplant Proc 23: 3071-3074
14. Japanese TAC Study Group 1993 Japanese study of TAC on kidney transplantation: results of late phase II study. Transplant Proc 25: 649-654
15. Japanese FK 506 Study Group 1991 Clinicopathological evaluation of kidney transplants in patients given a fixed dose of FK 506. Transplantation 23: 3111-3115
16. Japanese FK 506 Study Group 1993b Morphological characteristics of renal allografts showing renal dysfunction under FK 506 therapy: is graft biopsy available to reveal the morphological findings corresponding with FK 506 nephropathy? Transplant Proc 25: 624-627
17. Japanese FK 506 Study Group 1994 Morphopathological findings of renal allografts under FK 506 therapy. Transplant Proc 26: 1933-1936
18. Kino T, Tanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T, Goto T, Okahura M, Kohsaka M, Aoki H, Ochiai T 1987b TAC, a novel immunosuppressant isolated from a Streptomyces II. Immunosuppressive effect of TAC in vitro. J Antibiot 40: 1256-1265
19. Lopez OL, Martinez AJ, Torre-Cisneros J 1991 Neuropathologic findings in liver transplantation: a comparative study of cyclosporine and TAC. Transplant Proc 23: 3181-3182
20. Mayer AD, Dmitrewski J, Squifflet JP, Besse T, Grabensee B, Klein B et al. 1997 Multicenter randomized trial comparing Tacrolimus (FK 506) and Cyclosporine in the prevention of renal allograft rejection. Transplantation 64 (3): 436-443
21. McCauley J, Fung JJ, Jain A, Starzl TE 1990 The effects of TAC on renal function after liver transplantation. Transplant Proc 22: 17-20
22. McCauley J, Takaya S, Fung J, Tzaskis A, Abu-Elmagd K 1991 The question of TAC nephrotoxicity after liver transplantation. Transplant Proc 23: 1444-1447
23. Mihatsch MJ, Gudat F, Ryffel B, Thiel G 1994 Cyclosporine nephropathy. In: Tisher CC, Brenner BB (eds) Renal Pathology J. B. Lippincott Company 2. Edition, Vol. II, p 1641-1682
24. Newstead CG 1997 Tacrolimus in renal transplantation. Nephrol Dial Transplant 12: 1312-1315
25. Ohara K, Billington R, James RW, Dean GA, Nishiyama M 1990 Toxicologic evaluation of TAC. Transplant Proc 22 (Suppl 1): 83-86
26. Randhawa PS, Shapiro R, Jordan ML, Starzl TE, Demetris AJ 1993 The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK 506. Am J Surg Pathol 17: 60-68
27. Randhawa PS, Tsamandas AC, Magnone M, Jordan M, Shapiro R, Starzl TE, Demetris AJ 1996 Microvascular changes in renal allografts associated with FK 506 (Tacrolimus) therapy. Am J Surg Pathol 20 (3): 306-312
28. Reyes J, Gayowski T, Fung J, Todo S, Alessiani M, Starzl TE 1990 Expressive dysphasia possibly related to TAC in two liver transplant recipients. Transplantation 50: 1043-1081
29. Strøm E, Thiel G, Mihatsch MJ 1994 Prevalence of cyclosporine associated arteriolopathy in renal transplant biopsies from 1981 to 1992. Transplant Proc 26: 2585-2587
30. The U. S. Multicenter TAC Liver Study Group 1994 A comparison of Tacrolimus (TAC) and Cyclosporine for immunosuppression in liver transplantation. N Engl J Med 331: 1110-1115
31. Thompson AW 1990 FK-506: Profile of an important new immunosuppressant. Transplant Rev 4: 1-13